×

Aegerion Pharmaceuticals Announces Presentation at the Leerink Partners Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the Leerink Partners 5th Annual Global Healthcare Conference in New York City. Chief Executive Officer Mary Szela and Chief Financial and Administrative Officer Gregory Perry are scheduled to present in a fireside chat on Thursday, February 11, 2016 at 3:30 p.m. ET.

The presentation will be webcast live and may be accessed for up to 30 days following the conference by visiting the “Investors” section of Aegerion’s website, www.aegerion.com.

About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com.

CONTACT: Aegerion Pharmaceuticals, Inc. Amanda Murphy Associate Director, Investor Relations 857-242-5024

Source:Aegerion Pharmaceuticals, Inc.

More From Press Releases